Cannabidiol hydroxyquinone

CAS No. 137252-25-6

Cannabidiol hydroxyquinone( —— )

Catalog No. M32381 CAS No. 137252-25-6

Cannabidiol hydroxyquinone(HU-331) might be an active metabolite of cannabidiol potentially contributing to the induction of apoptosis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 421 In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Cannabidiol hydroxyquinone
  • Note
    Research use only, not for human use.
  • Brief Description
    Cannabidiol hydroxyquinone(HU-331) might be an active metabolite of cannabidiol potentially contributing to the induction of apoptosis.
  • Description
    Cannabidiol hydroxyquinone(HU-331) might be an active metabolite of cannabidiol potentially contributing to the induction of apoptosis. HU-331 inhibits the ATPase activity of topoisomerase IIα using a noncompetitive mechanism.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    137252-25-6
  • Formula Weight
    328.45
  • Molecular Formula
    C21H28O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO, Pyridine, Methanol, Ethanol, etc.
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Toxicol Lett . 2010 May 19;195(1):68-74.
molnova catalog
related products
  • DI-N-OCTYL PHTHALATE

    Phthalate ester used as plasticizers and additives. Used in toxicology studies as well as risk assessment studies of food contamination that occurs via migration of phthalates into foodstuffs from food-contact materials (FCM).

  • SMS2-IN-1

    SMS2-IN-1 is a highly selective inhibitor of sphingomyelin synthase 2 (SMS2)(IC50 of 6.5 nM).

  • CGP 20376

    CGP 20376 is a benzothiazole compound, an anthelmintic, with dual dose-dependent modulation of in vitro effects on the respiratory burst of eosinophils and antifibrillatory properties.